TP53 and breast cancer: In the combined multicentric cohort, high ASPM expression was significantly associated with a higher grade, higher NPI score, ER negativity, PR negativity, HER2 positive status, P53 mutated types, and basal BC subtypes (Supplementary Figures S2–S5).